Insights / July 03, 2019 / by beaconlbs

Featured Lab-of-Choice: AmeriPath

BeaconLBS has invited the Labs-of-Choice™ to provide some more information about themselves for a blog series featuring each of the Labs-of-Choice. The following content was provided by the featured lab, AmeriPath.

AmeriPath is a leading national provider of anatomic pathology, dermatopathology and molecular diagnostic services to physicians, hospitals, clinical laboratories and surgery centers across the U.S.

Through our nationally based, board certified pathology teams and integrated state-of-the-art laboratory, AmeriPath is dedicated to providing comprehensive diagnostic solutions, advanced technology and testing, and superior pathology services to regional and local medical communities. We deliver a clearer path to greater diagnostic insights.

Our team of over 450 highly trained, board-certified pathologists and Ph.D. level scientists provide medical diagnostic services in outpatient laboratories owned, operated and managed by AmeriPath, as well as hospitals and ambulatory surgical centers.

For more information, visit AmeriPath.com.

You Might Also Like:

Molecular Genetics / June 11, 2019 / by beaconlbs

Liquid Biopsy in Cancer Diagnosis, Detection and Treatment

Recently, there has been much excitement about the potential for liquid biopsy’s possible applications in cancer detection, diagnosis, and treatment. Learn more about the current evidence of clinical utility of cell free DNA in our latest blog.

Insights / February 20, 2019 / by beaconlbs

The BeaconLBS Evidence-Based Process for Managing Lab Tests

BeaconLBS works with our health plan, employer and accountable care organization (ACO) partners to use evidence-based policies and guide lab test benefit management. Read about our four steps below.